MedTrace Logo

Pierre Robin Sequence Outcome Assessment Multi Institutional Study

NCT02432638 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-11-22

No results posted yet for this study

Summary

The purpose of this prospective, multi-center, longitudinal study is to assess clinical outcomes related to the surgical treatment of PRS ( Pierre Robin Sequence) by MDO (Mandibular distraction osteogenesis). This study aims to develop a scoring system to determine success and complication rate pre and post MDO.

Conditions

  • Pierre Robin Sequence

Sponsors & Collaborators

Principal Investigators

  • Roberto Flores, MD · NYU School of Medicine

Eligibility

Min Age
1 Day
Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-10-27
Completion
2017-10-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02432638 on ClinicalTrials.gov